Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
State Street Corp reported a 5.30% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 5.30% stake in Corvus Pharmaceuticals, Inc., 4,474,091 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 4,474,091
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.30% | 4,474,091 |
Source
Related
- Corvus Pharmaceuticals, Inc.
- State Street Corp
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Moore David Scott · Jun 15, 2026
- Form 4 · Miller Richard A Md · May 20, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026